Efficacy of plerixafor in children with malignant tumors failing to mobilize a sufficient number of hematopoietic progenitors with G-CSF.
Phase of Trial: Clinical Phase Unknown
Latest Information Update: 19 Nov 2015
At a glance
- Drugs Plerixafor (Primary)
- Indications Stem cell mobilisation
- Focus Expanded access; Therapeutic Use
- 19 Nov 2015 New trial record